Season 3 Episode 35
In this episode, Michael and Josh continue to unpick the thorny question of germ-cell tumours, focusing this week on more advanced and relapsed disease. Germ cell tumours have an excellent prognosis,…
Published on 1 day, 5 hours ago
Season 3 Episode 34
This episode is the first of a two-part mini-series where Michael and Josh attempt to untangle the complex topic of germ cell tumours, an area that requires specialist experience and a high-volume mu…
Published on 1 week, 1 day ago
Season 3 Episode 33
In this episode, Josh and Michael take a trip down a road less travelled by both patients and researchers, and examine the evidence (or lack thereof) of non-clear cell renal cell cancer, a less commo…
Published on 2 weeks ago
Season 3 Episode 32
How do you increase access to phase 1 trials for a state with a population of 8 million people spread across 800,000 km^2? You collaborate! In this context, we explore NECTA. The New South Wales Earl…
Published on 3 weeks ago
Season 3 Episode 31
Unlike the adjuvant space, treatment of advanced clear cell renal cell cancer has been a success story potentially only surpassed by advanced melanoma. What was once a horrific and quickly fatal dise…
Published on 4 weeks, 1 day ago
Season 3 Episode 30
Continuing on their Back to Basics GU extravaganza, Josh and Michael progress to the subject of kidney cancer, and bring you the answer to a question long unanswered: is there any benefit of adjuvant…
Published on 1 month ago
Season 3 Episode 29
Josh and Michael return to their normal scheduled broadcast, continuing their never-ending Back to Basics series. In this episode, they discuss several interesting developments in the adjuvant manage…
Published on 1 month, 1 week ago
Season 3 Episode 28
In our final ASCO 2025 episode, Michael is joined by Prof Jeanne Tie, colorecal cancer lead at Peter MacCallum Cancer Centre to discuss some of the many highlights in colorectal and anal cancer. Star…
Published on 2 months ago
Season 3 Episode 27
In this episode, Michael goes it alone, welcoming an old friend of the show, Dr Belinda Yeo, to discuss highlights in early breast cancer from ASCO 2025. The pair discuss an exciting new medication t…
Published on 2 months ago
Season 3 Episode 26
Today, hosts Michael and Josh are joined by the wonderful Dr James McCracken to discuss highlights from ASCO 2025 in the areas of upper GI and hepatobiliary cancer. This episode focuses on two items …
Published on 2 months, 1 week ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate